Home
LPCN
LPCN News

Latest Lipocine Inc. (LPCN) News on April 24, 2025

Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depression

Clinical Trials Arena

a month ago

Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depression

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154

PR Newswire

a month ago

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

PR Newswire

a month ago

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

Lipocine Announces FDA Labeling Changes for Testosterone Products

PR Newswire

a month ago

Lipocine Announces FDA Labeling Changes for Testosterone Products

Lipocine Receives Updated Regulatory Guidance on LPCN 1154

PR Newswire

3 months ago

Lipocine Receives Updated Regulatory Guidance on LPCN 1154

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Lipocine Says LPCN 1148 Gets FDA Fast Track Label

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis

PR Newswire

4 months ago

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session

PR Newswire

5 months ago

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024

PR Newswire

6 months ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024

Associated Press Finance

6 months ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea

PR Newswire

6 months ago

Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea

Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results

PR Newswire

6 months ago

Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results

Lipocine signs supply and distribution agreement with Pharmalink for Tlando

TipRanks

6 months ago

Lipocine signs supply and distribution agreement with Pharmalink for Tlando

MT Newswires

7 months ago

Lipocine Signs Exclusive Tlando Supply, Distribution Deal With Pharmalink

Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries

PR Newswire

7 months ago

Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024

PR Newswire

7 months ago

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference

PR Newswire

7 months ago

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference

Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®

PR Newswire

8 months ago

Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

8 months ago

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024

PR Newswire

9 months ago

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024

Associated Press Finance

9 months ago

Lipocine: Q2 Earnings Snapshot

Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study

PR Newswire

10 months ago

Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024

PR Newswire

10 months ago

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024

Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

a year ago

Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why

Here's Why Momentum in Lipocine (LPCN) Should Keep going

Zacks

a year ago

Here's Why Momentum in Lipocine (LPCN) Should Keep going

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024

PR Newswire

a year ago

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024

Associated Press Finance

a year ago

Lipocine: Q1 Earnings Snapshot

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024

PR Newswire

a year ago

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154

PR Newswire

a year ago

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

PR Newswire

a year ago

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis

PR Newswire

a year ago

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154

PR Newswire

a year ago

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023

PR Newswire

a year ago

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023

Lipocine to Present at 36th Annual Roth Conference

PR Newswire

a year ago

Lipocine to Present at 36th Annual Roth Conference

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154

PR Newswire

a year ago

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

PR Newswire

a year ago

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

5E Advanced Materials Closes Second Tranche of Equity Financing

GlobeNewswire

a year ago

5E Advanced Materials Closes Second Tranche of Equity Financing

eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

a year ago

eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

7 Stocks to Buy Now for Massive Growth Potential in 2024

InvestorPlace

a year ago

7 Stocks to Buy Now for Massive Growth Potential in 2024

GlobeNewswire

a year ago

QuantaSing Announces Appointment of New Independent Director

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

PR Newswire

a year ago

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

PR Newswire

a year ago

QuantaSing Unveils Private Label Chinese Baijiu Brand YUNTING

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers

GlobeNewswire

a year ago

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers

Business Wire

a year ago

Pagaya Announces Strategic Actions to Enhance Marketability of its Stock, Strong Financial Outperformance in 4Q23 and FY23

7 A-Rated Semiconductor Stocks to Buy in January

InvestorPlace

a year ago

7 A-Rated Semiconductor Stocks to Buy in January

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Simply Wall St.

a year ago

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024

PR Newswire

a year ago

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

News Direct

a year ago

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

We're Keeping An Eye On NeoVolta's (NASDAQ:NEOV) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On NeoVolta's (NASDAQ:NEOV) Cash Burn Rate

Lipocine to Present at Biotech Showcase 2024

PR Newswire

a year ago

Lipocine to Present at Biotech Showcase 2024

Pagaya Technologies Ltd.'s (NASDAQ:PGY) market cap up US$85m last week, benefiting both retail investors who own 25% as well as insiders

Simply Wall St.

a year ago

Pagaya Technologies Ltd.'s (NASDAQ:PGY) market cap up US$85m last week, benefiting both retail investors who own 25% as well as insiders

Business Wire

a year ago

Pagaya Announces Partnership with Exeter Finance, Further Scaling its Auto Lending Product

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive

Simply Wall St.

a year ago

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive

Thomson Reuters StreetEvents

a year ago

Q3 2023 Burning Rock Biotech Ltd Earnings Call

Burning Rock Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Burning Rock Reports Third Quarter 2023 Financial Results

Pagaya Technologies Names Former Xerox Executive Nicole Torraco to its Board of Directors

Business Wire

a year ago

Pagaya Technologies Names Former Xerox Executive Nicole Torraco to its Board of Directors

PR Newswire

a year ago

iClick Interactive Asia Group Limited Enters into a Definitive Merger Agreement for Going-Private Transaction

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

GlobeNewswire

a year ago

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

PR Newswire

a year ago

Prenetics Announces Third Quarter 2023 Financial Results

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

Arqit Sets Fiscal Year 2023 Conference Call for Tuesday, November 21, 2023 at 11:00 a.m. ET

GlobeNewswire

a year ago

Arqit Sets Fiscal Year 2023 Conference Call for Tuesday, November 21, 2023 at 11:00 a.m. ET

Thomson Reuters StreetEvents

a year ago

Q3 2023 BioXcel Therapeutics Inc Earnings Call

GuruFocus.com

a year ago

Reneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Results

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Insider Monkey

a year ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

PR Newswire

a year ago

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

Simply Wall St.

a year ago

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

PLBY Group, Inc. (NASDAQ:PLBY) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

PLBY Group, Inc. (NASDAQ:PLBY) Q3 2023 Earnings Call Transcript

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript

Associated Press Finance

a year ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

PR Newswire

a year ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

Associated Press Finance

a year ago

Western Copper: Q3 Earnings Snapshot

ACCESSWIRE

a year ago

TG Venture Acquisition Corp. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement

Curo Group (CURO) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a year ago

Curo Group (CURO) Reports Q3 Loss, Lags Revenue Estimates

REE Automotive Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

a year ago

REE Automotive Regains Compliance with Nasdaq Minimum Bid Price Requirement

Prenetics Global Limited Announces Reverse Stock Split

GlobeNewswire

a year ago

Prenetics Global Limited Announces Reverse Stock Split

Stabilis Solutions Announces Multi-Year LNG Bunkering Contract with Carnival Corporation

ACCESSWIRE

a year ago

Stabilis Solutions Announces Multi-Year LNG Bunkering Contract with Carnival Corporation

Share on Social Networks: